XML 46 R26.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
STOCKHOLDERS' EQUITY  
Schedule of common stock issued roll forward

The following table represents a share reconciliation of the Company’s common stock issued for the periods presented:

 

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

Common stock:

Balance, beginning of period

201,449,583

189,947,235

195,028,207

183,606,708

Shares issued for stock options exercised

10,264

95,037

82,546

320,481

Agent growth incentive stock-based compensation

662,874

308,790

1,968,559

1,341,303

Agent equity stock-based compensation

2,520,959

2,208,226

7,564,368

7,290,796

Balance, end of period

204,643,680

192,559,288

204,643,680

192,559,288

Changes in the Company's stock compensation liability

The following table illustrates changes in the Company’s stock-based compensation liability for the periods presented:

Amount

Balance, December 31, 2023

$ 5,000

Stock grant liability increase year to date

2,251

Stock grants reclassified from liability to equity year to date

(2,206)

Balance, December 31, 2024

$ 5,045

Stock grant liability increase year to date

1,732

Stock grants reclassified from liability to equity year to date

(928)

Balance, September 30, 2025

$ 5,849

Schedule of shares repurchased

The following table shows the share changes in treasury stock for the periods presented (not in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

Treasury stock:

Balance, beginning of period

44,217,271

36,213,862

40,894,822

28,937,671

Repurchases of common stock

1,589,685

2,794,040

4,912,134

10,070,231

Balance, end of period

45,806,956

39,007,902

45,806,956

39,007,902